The US FDA has granted accelerated approval to atrasentan (Vanrafia) for reducing proteinuria in adults with primary ...

Novartis strengthens its renal disease portfolio with accelerated approval of another drug for immunoglobulin A nephropathy.

Among patients with diabetes receiving PCI, novel antidiabetic agents may reduce risk for acute kidney injury.

Tagrisso is associated with positive outcomes among patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer ...

DBM Global fourth quarter revenue of $225.7 million -- Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) system received FDA ...

The first-line combination of amivantamab-vmjw plus lazertinib extended OS compared with osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer, according to data from the ...

The following is a summary of “Long-term effect of tolvaptan treatment on kidney function and volume in patients with ADPKD,” ...

Aloha, GNOME 48 — a new version of the GNOME desktop environment is out with a swathe of new features, UI buffs, and technical integrations that will have plenty of folks clamouring to upgrade. GNOME ...

Chrissy Sarnowsky is on the Survivor 48 cast. Pic credit: Robert Voets/CBS A new Survivor 48 episode aired on Wednesday night. This was the fourth episode of the season, with 15 people still ...

Jeff Probst, Sai Hughley, Mary Zheng, and Cedrek McFadden on 'Survivor 48' ...

AstraZeneca has released two sets of data showing the promise of different drug combinations in treating EGFR-mutated lung cancer following Tagrisso.

Detailed price information for Greenfire Resources Ltd. (GFR-T) from The Globe and Mail including charting and trades.